Clinical Trials
5 trialsNCT04939090 2026-04-13
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT02116530 2025-01-28
Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT05403580 2024-05-06
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
Mayo Clinic
Phase 3 Withdrawn
NCT02635984 2018-08-20
FOND-O
Augusta University
Phase 3 Completed
NCT00737191 2012-03-09
Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain
Mayo Clinic
Phase NA Withdrawn